🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Carmen Ledesma‐Feliciano

PharmaJet (United States)

ORCID: 0000-0001-9589-6214
Immunology and MicrobiologyBiochemistry, Genetics and Molecular BiologyMedicineAgricultural and Biological Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: Broad antiviral and anti‐inflammatory efficacy of nafamostat against SARS‐CoV‐2 and seasonal coronaviruses in primary human bronchiolar epithelia.

11 citations

Caitlin M. Miller, Carmen Ledesma‐Feliciano, James H. Morrison, Rocío J. Jiménez-Valdés, Clarissa Clifton +3 more

7 citations

Carmen Ledesma‐Feliciano, Rwik Sen, Navneet Dogra